kwic
disease
disease
right
off
ON
124
1
100
500
strict
ELIZA cgi-bash version rev. 1.90
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for disease out of >500 occurrences
422715 occurrences (No.39 in the rank) during 5 years in the PubMed. [no cache] 500 found
--- ABSTRACT ---
--- ABSTRACT END ---
[frequency of next (right) word to disease]
422715 occurrences (No.39 in the rank) during 5 years in the PubMed. [no cache] 500 found
| 124) This review will outline the management of patients with symptomatic systolic heart failure or heart failure with reduced ejection fraction (HFrEF), i.e., those with structural heart disease and previous or current symptoms. |
| PMID:24251455 DOI:10.1111/jan.12297 |
| 2015 Current cardiology reviews |
| * A practical guide for the treatment of symptomatic heart failure with reduced ejection fraction (HFrEF). |
| - This review will outline the management of patients with symptomatic systolic heart failure or heart failure with reduced ejection fraction (HFrEF), i.e., those with structural heart disease and previous or current symptoms. Determination of volume status and appropriate diuretic administration is important in heart failure management. Inhibition of the renin-angiotensin-aldosterone and sympathetic nervous systems improves survival and decreases hospitalizations in patients with systolic or reduced ejection fraction HF (HFrEF). Beta blockers and aldosterone antagonists improve ejection fraction. Indications for additional agents including nitrates plus hydralazine, digoxin, statins, omega 3 polyunsaturated fatty acids, anticoagulants, and antiarrhythmics will be discussed. Choice of agents, dose-related effects, strategies to minimize adverse effects, and medications to avoid will be presented. |
[
right
kwic]
| (1)100 *null* | (17)4  (PD) |
(33)3 to |
(49)2 condition, |
| (2)39 and |
(18)4 activity |
(34)2 (CHD) |
(50)2 development |
| (3)16 is |
(19)4 outcome |
(35)2 (COPD) |
(51)2 interval |
| (4)13 in |
(20)4 severity, |
(36)2 (CVD), |
(52)2 many |
| (5)12 of |
(21)4 the |
(37)2 (GERD) |
(53)2 multi-sectoral |
| (6)9 (FMD) |
(22)4 who |
(38)2 (LSD) |
(54)2 on |
| (7)8 risk |
(23)3 (CAD) |
(39)2 (SC) |
(55)2 onset |
| (8)7 severity |
(24)3 compared |
(40)2 Control |
(56)2 onset, |
| (9)6 progression |
(25)3 control |
(41)2 activity, |
(57)2 outbreaks |
| (10)6 that |
(26)3 course |
(42)2 are |
(58)2 patterns |
| (11)6 was |
(27)3 free |
(43)2 as |
(59)2 phobia |
| (12)5 (CVD) |
(28)3 has |
(44)2 associated |
(60)2 prevention |
| (13)5 or |
(29)3 management |
(45)2 burden |
(61)2 processes |
| (14)5 state |
(30)3 may |
(46)2 by |
(62)2 progression, |
| (15)4 (AD) |
(31)3 patients |
(47)2 can |
(63)2 surveillance |
| (16)4 (HD) |
(32)3 states |
(48)2 characterized |
(64)2 usually |
add keyword
--- WordNet output for disease ---